Education and participation in children and adolescents with Duchenne muscular dystrophy in Switzerland
Quality of life in Duchenne muscular dystrophy has been reported to be negatively affected by the lack of qualifying education and the lack of opportunities for participation in leisure activities. Two thirds of patients with Duchenne muscular dystrophy have cognitive and/or psychiatric problems. Thus, we conducted a survey study on mobility, school problems, executive functions, social participation and quality of life in young patients in Switzerland. We contacted 60 male patients with Duchenne muscular dystrophy aged 8-18 years through the Swiss Registry for Neuromuscular Disorders. Mobility, school problems and social participation in leisure activities were assessed with a self-constructed questionnaire. Quality of life and executive function were assessed using KIDSCREEN-10 and BRIEF scores, respectively. Out of 60 dispatched surveys, 67 % were filled out and included. Approximately half of the participants went to a special needs school, and 83 % rated their overall quality of life as good. We did not find a correlation between mobility and quality of life, whereas more social participation was correlated with higher quality of life. Furthermore, patients with more difficulties in executive functions showed less participation and lower quality of life. These results underline the need for neuropsychological and adapted assistance in patients with Duchenne muscular dystrophy to facilitate education and social participation.
Authors
- Sarah J. Erni
- Andrea Klein (ORCID: https://orcid.org/0000-0003-2733-5911)
- Dominique Baumann
- Eleftheria Michalopoulou
- Leonie Steiner
- Nadine Lötscher
- Bettina Henzi
- Anne Tscherter (ORCID: https://orcid.org/0000-0002-6972-482X)
Institutions
- University of Bern (CH)
- University of Zurich (CH)
- University of St.Gallen (CH)
- University Hospital of Bern (CH)
- Laboratory for Biomedical Neurosciences (CH)
- Ospedale San Giovanni Bellinzona (CH)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
- Luzerner Kantonsspital (CH)
- Kantonsschule Alpenquai Luzern (CH)
- University Children’s Hospital Bern (CH)
- University Children’s Hospital Basel (CH)
- University Children's Hospital Zurich (CH)
- Institute of Social and Preventive Medicine (CH)
- Kantonsspital Aarau (CH)
- Ostschweizer Kinderspital (CH)
- Istituto Pediatrico della Svizzera Italiana
- University of Lausanne (CH)
Publication Details
- Journal
- European Journal of Paediatric Neurology
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.ejpn.2025.03.010
- Citations
- 1
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Pfizer
- Roche
- PTC Therapeutics
- Sarepta Therapeutics